A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis

Clinical trial NCT03142191 · TERMINATED

Trial details

NCT number: NCT03142191
Sponsor: Celgene
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis Fibrosis Idiopathic Interstitial Pneumonias Pathologic Processes Lung Diseases, Interstitial Lung Diseases Respiratory Tract Diseases

Start date: 2017-07-26
Primary completion: 2021-12-24
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.